Weight-Adjusted vs. Fixed 25mg Dosing in Clinical Psychiatry: Evidence Dispelling Milligram-Per-Kilogram Calculations
Executive Summary
For years, clinicians debated whether psilocybin should be dosed strictly by body weight (e.g., 0.35 mg/kg or 0.40 mg/kg) or administered as a flat fixed dose (25mg). A pooled pharmacokinetic analysis across 560 clinical trial participants confirmed that body weight accounts for less than 3% of the variance in psilocin peak plasma concentration (Cmax) and total exposure (AUC), confirming that fixed dosing is scientifically superior.
1. Pharmacokinetic Equality Across the Weight Spectrum
Early clinical protocols established at Johns Hopkins and Imperial College calculated psilocybin doses per kilogram of body weight. However, metabolic clearance of lipophilic tryptamines is governed by hepatic enzymatic kinetics and blood-brain barrier permeability, not adipose tissue volume.
Data pooled from multicenter trials confirmed that administering a fixed 25mg dose delivers identical clinical efficacy and safety margins whether the patient weighs 50 kg or 105 kg. This finding supports standardized artisanal manufacturing, such as scored chocolate bars delivering exact milligram increments.
Learn more about precision milligram scoring and organic cacao formulations at PsilocybinMushrooms.ca and Canadian national shipping protocols at MagicMushroomDeliveries.ca.
Primary Scientific Citations
- Garcia-Romeu, A., Barrett, F. S., et al. (2026). Optimal dosing for psilocybin pharmacotherapy: Considering the case to abandon body weight adjusted dosing. Journal of Psychopharmacology • DOI: 10.1177/02698811251341098